This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Benjamin Adams
Introduction
Benjamin Adams is a notable inventor based in Mount Vernon, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of purification platforms for bispecific antibodies. His work is essential for advancing therapeutic applications in medicine.
Latest Patents
Adams holds a patent for a purification platform for bispecific antibodies. This innovative technology utilizes high-resolution protein A chromatography, employing a chaotropic agent and pH gradient or pH step elution buffer. This method results in improved peak resolution between closely related molecular species. The patent details the separation of bispecific antibodies containing a protein A-binding-ablating substitution CH3 domain paired with a protein A-binding CH3 domain from monospecific antibodies. Useful chaotropic agents mentioned in the patent include magnesium chloride and calcium chloride.
Career Highlights
Benjamin Adams is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in protein purification techniques has positioned him as a valuable asset in his field.
Collaborations
Adams has worked alongside talented colleagues such as Andrew Tustian and Christine Endicott. Their collaborative efforts have further enhanced the innovative projects at Regeneron Pharmaceuticals.
Conclusion
Benjamin Adams exemplifies the spirit of innovation in biotechnology through his patent and contributions to the field. His work not only advances scientific understanding but also has the potential to improve therapeutic outcomes for patients.